Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
571,163,077
-
Share change
-
-5,488,410
-
Total reported value
-
$8,054,591,803
-
Put/Call ratio
-
69%
-
Price per share
-
$14.11
-
Number of holders
-
477
-
Value change
-
-$17,524,572
-
Number of buys
-
235
-
Number of sells
-
159
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q1 2024
As of 31 Mar 2024,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) was held by
477 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
571,163,077 shares.
The largest 10 holders included
BlackRock Inc., Ion Asset Management Ltd., Phoenix Holdings Ltd., Migdal Insurance & Financial Holdings Ltd., Clal Insurance Enterprises Holdings Ltd, MENORA MIVTACHIM HOLDINGS LTD., Slate Path Capital LP, Lingotto Investment Management LLP, FMR LLC, and Rubric Capital Management LP.
This page lists
473
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.